Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Novartis prepares orally active iron chelators

July 23, 1997

Dose-response trial of LAAM in opioid-dependent subjects

July 17, 1997

Smoking cessation treatment launched in the U.S.

July 10, 1997

Tolerance to benzodiazepine hypnotics overcome with melatonin

June 6, 1997

DynaGen licenses smoking cessation technology

June 6, 1997

FDA clears Glaxo Wellcome's aid to smoking cessation

May 16, 1997

ImmuLogic receives funds from NIH to develop cocaine vaccine

May 12, 1997

Nicotine inhaler cleared by FDA

May 7, 1997

Alza and SmithKline Beecham sign new agreement for Nicoderm

April 22, 1997

Ibogamine congeners for addiction

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....